Genetic Variation in the Peroxisome Proliferator-Activated Receptor-γ2 Gene (Pro12Ala) Affects Metabolic Responses to Weight Loss and Subsequent Weight Regain

Diabetes

Volumn 50, Issue 9, 2001, Pages 2172-2176

  Nicklas, Barbara J ^a,b   Van Rossum, Elisabeth F C ^a   Berman, Dora M ^a   Ryan, Alice S ^a   Dennis, Karen E ^a   Shuldiner, Alan R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Baltimore VA Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; FEMALE; FORECASTING; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; METABOLISM; MIDDLE AGED; PHYSIOLOGY; WEIGHT REDUCTION;

AMINO ACID SEQUENCE; FEMALE; FORECASTING; GENOTYPE; HUMANS; METABOLISM; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; VARIATION (GENETICS); WEIGHT LOSS;

EID: 0035461855     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.9.2172     Document Type: Article

References (19)

1. Auwerx J: PPARgamma, the ultimate thrifty gene. Diabetologia 42:1033-1049, 1999
2. Yen C-J, Beamer B, Negri C, Silver K, Brown K, Yarnall D, Burns D, Roth J, Shuldiner A: Molecular scanning of the human peroxisome proliferates activated receptor gamma (hPPARgamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Comm 241:270-274, 1997
3. Deeb S, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimot W, Auwerx J: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287, 1998
4. Masugi J, Tamori Y, Mori H, Koike T, Kasuga M: Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun 268:178-182, 2000
5. Cole S, Mitchell B, Hsueh W-C, Pineda P, Beamer B, Shuldiner A, Comuzzie A, Blangero J, Hixson J: The Pro12Ala variant of peroxisome-proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes 24:522-524, 2000
6. Beamer B, Yen C-J, Andersen R, Muller D, Elahi D, Cheskin L, Andres R, Roth J, Shuldiner A: Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806-1808, 1998
7. Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb S, Auwerx J, Uusitupa M, Laakso M: Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 84:3708-3712, 1999
8. Mori Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer B, Shuldiner A, Akanuma Y, Yazaki Y, Kadowaki T: Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Comm 251:195-198, 1998
9. Clement K, Hercberg S, Passinge B, Galan P, Varroud-Vial M, Shuldiner AR, Beamer BA, Charpentier G, Guy-Grand B, Froguel P, Vaisse C: The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes 24:391-393, 2000
10. Oh E, Min K, Chung J, Min Y, Lee M, Kim K, Lee M: Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 85:1801-1804, 2000
11. Randle P, Garland P, Hales C, Newsholme E: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
12. Miles P, Barak Y, He W, Evans R, Olefsky J: Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invent 105:287-292, 2000
13. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekiliara H, Hasegawa CJ, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T: PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609, 1999
14. Ek J, Urhammer S, Sorensen T, Andersen T, Auwerx J, Pedersen O: Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamrna2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42:892-895, 1999
15. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, Hagura R, Akanuma Y, Kimura S, Ito C, Kadowaki T: The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 29:212-216, 2000
16. Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Renn W, Haring H: The PPARgamma2 amino acid polymorphism Pro12Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia 42:758-762, 1999
17. Barroso I, Gurnell M, Crowley V, Agostini M, Schwabe J, Soos M, Maslen G, Williams T, Lewis H, Schafer A: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-883, 1999
18. Nicklas B, Goldberg A, Bunyard L, Poehlman E: Visceral adiposity is associated with increased lipid oxidation in obese, postmenopausal women. Am J Clin Nutr 62:981-922, 1995
19. Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L: Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes 23:512-517, 1999.